{"title":"Biodegradable occluders for patent foramen ovale closure: toward the next generation of structural heart intervention.","authors":"Teiji Akagi","doi":"10.21037/cdt-2026-0255","DOIUrl":"10.21037/cdt-2026-0255","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"91"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Passion flows within me.","authors":"Natalie Brillhart","doi":"10.21037/cdt-2026-0454","DOIUrl":"https://doi.org/10.21037/cdt-2026-0454","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"96"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nikhil Singh, Pankaj K Jain, Rubeena Vohra, Arun K Dubey, Mainak Biswas, Ekta Tiwari, Vinod Anand, Inder M Singh, Esma R Isenovic, Amer M Johri, Laura E Mantella, John R Laird, Narendra N Khanna, Zoltan Ruzsa, Rajesh Singh, Sanjay Saxena, Mustafa Al Maini, Klaudija Viskovic, Manudeep K Kalra, Andrew Nicolaides, George Kitas, Vijay Viswanathan, Janet N A Ajuluchukwu, Luca Saba, Jasjit S Suri
{"title":"A comparative study of the state-of-the-art artificial intelligence models for automated plaque measurement in a carotid ultrasound Japanese cohort.","authors":"Nikhil Singh, Pankaj K Jain, Rubeena Vohra, Arun K Dubey, Mainak Biswas, Ekta Tiwari, Vinod Anand, Inder M Singh, Esma R Isenovic, Amer M Johri, Laura E Mantella, John R Laird, Narendra N Khanna, Zoltan Ruzsa, Rajesh Singh, Sanjay Saxena, Mustafa Al Maini, Klaudija Viskovic, Manudeep K Kalra, Andrew Nicolaides, George Kitas, Vijay Viswanathan, Janet N A Ajuluchukwu, Luca Saba, Jasjit S Suri","doi":"10.21037/cdt-2026-0347","DOIUrl":"10.21037/cdt-2026-0347","url":null,"abstract":"<p><strong>Background: </strong>Automated carotid intima-media thickness (cIMT) measurement from B-mode ultrasound is important for cardiovascular risk stratification. Direct comparisons of deep learning architectures on the same cohort under controlled conditions remain limited. This study aimed to compare the accuracy and computational cost of three deep learning architectures with the commercial AtheroEdge™ 2.0 (AE 2.0) system for carotid ultrasound analysis.</p><p><strong>Methods: </strong>This study evaluated three deep learning architectures: carotid non-attention double-stage convolutional neural network (cNonAtt-dsCNN), carotid attention-based single-stage UNet (cAtt-ssUNet), and carotid attention-based double-stage UNet (cAtt-dsUNet) against the commercial AE 2.0 system on 400 carotid ultrasound images from 200 Japanese patients. All deep learning models were trained using identical preprocessing, augmentation, hyperparameters (Adam optimizer, learning rate =1e-4, batch =32), and 5-fold cross-validation. Evaluation metrics included Dice similarity coefficient (DSC), Jaccard index, lumen-intima error (LIe), media-adventitia error (MAe), intima-media thickness error (IMTe), and computational cost.</p><p><strong>Results: </strong>Under identical conditions, cAtt-dsUNet achieved the highest accuracy [DSC: 91.2%, Jaccard index: 85.5%, correlation coefficient (CC): 0.98, LIe: 0.031 mm, IMTe: 0.022 mm], reaching commercial-grade overlap and correlation but at ~2.5× longer training (20.2 <i>vs.</i> 8 min) and ~1.7× more graphics processing unit (GPU) memory than cNonAtt-dsCNN (DSC: 81.5%, CC: 0.92, LIe: 0.09 mm, IMTe: 0.124 mm). cAtt-ssUNet was intermediate (DSC: 88.5%, CC: 0.95, LIe: 0.07 mm). AE 2.0 retained the lowest boundary errors (LIe: 0.012 mm, IMTe: 0.011 mm) with 6 ms inference.</p><p><strong>Conclusions: </strong>A clear trade-off between accuracy-efficiency exists across the evaluated methods. cAtt-dsUNet is optimal for high-accuracy research settings with adequate GPU resources, while cNonAtt-dsCNN and AE 2.0 are preferable for speed-critical clinical screening. The single-cohort Japanese dataset limits generalizability; multi-center, multi-ethnic validation is recommended before clinical deployment.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"89"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Physical activity at moderate altitude: risk or benefit for the heart?","authors":"Martin Burtscher, Benjamin Levine","doi":"10.21037/cdt-2026-0235","DOIUrl":"10.21037/cdt-2026-0235","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"80"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Role of the CXCL8-CXCR2 axis in obesity-related atrial fibrillation: integrated bioinformatics and experimental validation.","authors":"Yu-Fei Dai, Hai-Wei Geng, Huan-Huan Liu, Ying Liu, Yue Wang, Xiao-Yu Liu, Ling-Ling Qian, Ru-Xing Wang","doi":"10.21037/cdt-2026-0182","DOIUrl":"10.21037/cdt-2026-0182","url":null,"abstract":"<p><strong>Background: </strong>Obesity is a common risk factor for atrial fibrillation (AF), two conditions which frequently coexist in modern populations. Therefore, this study aimed to identify the genes associated with increased AF susceptibility in obese individuals and to identify biomarkers for obesity-related AF.</p><p><strong>Methods: </strong>We identified hub genes by integrating the transcriptomic datasets of patients with AF and those of obese individuals with plasma proteomics data from the UK Biobank. A diet-induced obesity (DIO) mouse model was then established, and AF was induced via the injection of s acetylcholine-calcium chloride mixture into the tail vein. Transcriptomic analysis, quantitative polymerase chain reaction (qPCR), and Western blotting were used to validate the expression of hub genes. Finally, the Microenvironment Cell Populations-counter method was used to characterize the atrial immune landscape in AF-susceptible DIO mice.</p><p><strong>Results: </strong>Five AF-related genes involved in obesity were identified through the intersection of differentially expressed genes (DEGs) with a weighted gene coexpression network module. Using machine learning algorithms and RNA sequencing, we identified C-X-C motif chemokine receptor 2 (<i>CXCR2</i>) as a biomarker for obesity-related AF. Analysis of the plasma proteomics data from the UK Biobank showed that higher plasma C-X-C motif chemokine ligand 8 (CXCL8) levels were associated with a higher body mass index and an increased risk of AF and flutter. According to bioinformatics analysis, <i>CXCL8</i> expression was non-significantly increased in the atria of obese patients and was significantly increased in the whole blood and epicardial adipose tissue (EAT) of overweight/obese individuals. AF susceptibility was heightened in DIO mice, and AF-susceptible DIO mice exhibited elevated atrial murine functional analogs of human CXCL8 and CXCR2 expression. Immune infiltration analysis and gene set enrichment analysis revealed immune dysfunction in the atria of AF-susceptible DIO mice.</p><p><strong>Conclusions: </strong>Our findings suggest that the CXCL8-CXCR2 axis may be involved in the increased susceptibility to AF of obese individuals, highlighting its potential as a biomarker and warranting further therapeutic investigation.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"86"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chang Wang, Xue Zhou, Yu Liu, Mengchen Li, Yuyang Sun, Xinran Zhao, Yan Sun, Xiaoli Liu
{"title":"Association of ticagrelor versus clopidogrel with in-hospital early outcomes in elderly patients with acute myocardial infarction complicated by cardiogenic shock: findings from CCC-ACS project.","authors":"Chang Wang, Xue Zhou, Yu Liu, Mengchen Li, Yuyang Sun, Xinran Zhao, Yan Sun, Xiaoli Liu","doi":"10.21037/cdt-2026-0264","DOIUrl":"10.21037/cdt-2026-0264","url":null,"abstract":"<p><strong>Background: </strong>Elderly patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) have a markedly high mortality. Although ticagrelor has demonstrated superiority over clopidogrel in the AMI population, its efficacy and safety in elderly patients with AMI-CS remain uncertain. This study aimed to compare the associations of ticagrelor and clopidogrel with early in-hospital clinical outcomes in elderly patients with AMI-CS.</p><p><strong>Methods: </strong>This retrospective study included 839 patients aged ≥65 years with AMI-CS who underwent percutaneous coronary intervention (PCI) at participating hospitals in China within the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project between November 2014 and December 2020. Patients with missing information on dual antiplatelet therapy (DAPT), those who did not receive DAPT within 24 hours of first medical contact, and those with combined use of or switching between P2Y12 inhibitors during hospitalization were excluded. Patients were grouped according to the P2Y12 inhibitor received: ticagrelor (n=314) or clopidogrel (n=525). The primary outcomes were all-cause mortality and major bleeding during the first 15 days of hospitalization; major adverse cardiovascular events (MACE) were a secondary outcome. Multivariable Cox regression, propensity score matching (PSM), and inverse probability of treatment weighting (IPTW) were used to adjust for potential confounders.</p><p><strong>Results: </strong>Compared with clopidogrel, ticagrelor was associated with higher risk of all-cause mortality [adjusted hazard ratio (HR) 1.52, 95% confidence interval (CI): 1.05-2.21, P=0.03] and MACE (adjusted HR 1.48, 95% CI: 1.09-2.01, P=0.01) during the first 15 days of hospitalization, without a statistically significant difference in major bleeding (adjusted HR 1.76, 95% CI: 0.68-4.52, P=0.24). Subgroup analyses generally showed a similar direction of association for all-cause mortality. The associations with mortality and MACE remained statistically significant after PSM; the corresponding IPTW estimates were directionally similar but not statistically significant.</p><p><strong>Conclusions: </strong>Among elderly AMI-CS patients undergoing PCI, ticagrelor did not confer a clinical benefit over clopidogrel and was associated with increased in-hospital mortality and MACE without a significant increase in major bleeding. These findings highlight the need for cautious selection of P2Y12 inhibitors in this high-risk population and further prospective studies to guide individualized therapy.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"87"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Echocardiographic response and predictors of reverse remodeling after sacubitril/valsartan in <i>de novo</i> heart failure with reduced ejection fraction: cohort study.","authors":"In Tae Moon, Sung Hun Park, Jung Yeon Chin","doi":"10.21037/cdt-2026-0233","DOIUrl":"10.21037/cdt-2026-0233","url":null,"abstract":"<p><strong>Background: </strong>Sacubitril/valsartan (angiotensin receptor-neprilysin inhibitor, ARNI) improves outcomes in heart failure with reduced ejection fraction (HFrEF), yet treatment response varies and predictors of response remain incompletely defined. We aimed to evaluate real-world echocardiographic responses to ARNI and identify predictors of favorable response in patients with newly diagnosed HFrEF.</p><p><strong>Methods: </strong>Consecutive patients who initiated ARNI at Uijeongbu Eulji University Hospital between March 2021 and August 2024 were prospectively enrolled. Echocardiographic reverse remodeling was assessed by changes in left ventricular (LV) ejection fraction (EF). Based on the degree of echocardiographic response, patients were categorized as nonresponders [follow-up left ventricular ejection fraction (LVEF) <40% and an absolute increased in LVEF <10%], partial responders (follow-up LVEF ≥40% and <50%, or an absolute increase in LVEF ≥10% with follow-up LVEF <50%), or super responders (follow-up LVEF ≥50%). Clinical outcomes were assessed using Kaplan-Meier analysis, and predictors of response were evaluated using multivariable logistic regression.</p><p><strong>Results: </strong>Among 392 patients who completed follow-up echocardiography (median follow-up interval, 11.0 months), 116 (29.6%) were nonresponders, 110 (28.0%) were partial responders, and 166 (42.3%) were super responders with a recovery of LVEF ≥50%. During a median follow-up of 708 days, nonresponders experienced significantly higher rates of clinical events, including death or heart failure rehospitalization, compared with responders (P<0.001). In multivariable analysis, higher baseline systolic blood pressure [SBP; odds ratio (OR), 1.249; 95% confidence interval (CI): 1.120-1.400] and smaller LV end-diastolic volume (OR 0.919; 95% CI: 0.869-0.970) were independently associated with favorable echocardiographic response. Although a substantial proportion of patients did not achieve ARNI doses ≥200 mg/day, exploratory analysis did not demonstrate a significant association between ARNI dose and echocardiographic response or clinical outcomes.</p><p><strong>Conclusions: </strong>In this real-world cohort study, ARNI therapy was associated with substantial reverse remodeling and improved clinical outcomes despite low rates of target-dose attainment. Baseline SBP and LV remodeling parameters were associated with treatment response, supporting individualized ARNI titration strategies in clinical practice.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"82"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nfia-mediated troponin C activation enhances pluripotent stem cell-derived cardiomyocyte function and improves cardiac remodeling after myocardial infarction.","authors":"Chan Wang, Jiarui Shen, Hui Shen, Xiaochen Yuan","doi":"10.21037/cdt-2026-0162","DOIUrl":"10.21037/cdt-2026-0162","url":null,"abstract":"<p><strong>Background: </strong>Myocardial infarction (MI) causes irreversible cardiomyocyte loss and adverse ventricular remodeling because of the limited regenerative capacity of adult cardiomyocytes. Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) represent a promising strategy for myocardial repair, but their therapeutic efficacy is limited by incomplete maturation and insufficient functional integration. This study investigated whether nuclear factor I A (Nfia) enhances PSC-CM-mediated cardiac repair and explored its downstream mechanism.</p><p><strong>Methods: </strong>Public single-cell RNA sequencing (scRNA-seq) data from male post-MI mouse hearts and a mouse PSC-CM differentiation dataset were analyzed to characterize post-infarction remodeling and screen candidate transcriptional regulators. Mouse PSCs/PSC-CMs were modified by lentiviral Nfia overexpression and troponin C (TnC) silencing and evaluated by quantitative reverse transcription polymerase chain reaction (RT-qPCR), Western blotting, immunofluorescence, calcium transient analysis, dual-luciferase reporter assays, and chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR). Engineered PSCs were transplanted into 10-week-old male C57BL/6N mice after MI induction by left anterior descending coronary artery ligation. Sham, MI, control PSC, Nfia-overexpressing PSC, and TnC-silenced rescue groups were used to assess cardiac function, fibrosis, cardiomyocyte hypertrophy, and lineage marker expression.</p><p><strong>Results: </strong>Post-MI cardiac tissue exhibited sustained cellular remodeling, fibrotic activation, and impaired endogenous cardiomyocyte recovery, supporting the need for PSC-CM-based repair. Nfia was identified as a candidate regulator during PSC-CM differentiation. Nfia overexpression enhanced cardiomyogenic marker expression, sarcomere organization, and calcium-handling capacity in PSC-CMs. Mechanistically, Nfia directly bound to the TnC promoter and activated TnC transcription. <i>In vivo</i>, transplantation of Nfia-overexpressing PSCs improved left ventricular function and attenuated adverse remodeling after MI, whereas TnC silencing weakened these reparative effects.</p><p><strong>Conclusions: </strong>Nfia enhances the maturation and reparative capacity of PSC-CMs, at least in part by activating TnC transcription. The Nfia-TnC regulatory axis may provide a potential strategy to improve stem cell-based myocardial repair after MI.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"84"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Time-zero multimodal risk stratification for in-hospital mortality in acute aortic dissection: two-centre development, temporal and external validation, and occult shock phenotyping.","authors":"Ling Zhou, Wenqing Gong, Lei Shang, Liwen Liu, Weixun Duan, Minjuan Zheng","doi":"10.21037/cdt-2026-0334","DOIUrl":"10.21037/cdt-2026-0334","url":null,"abstract":"<p><strong>Background: </strong>Acute aortic dissection (AAD) requires rapid anatomical diagnosis and early risk stratification, yet initial blood pressure alone may miss patients with concealed hypoperfusion. Although computed tomography angiography (CTA) defines dissection anatomy and transthoracic echocardiography (TTE) provides bedside haemodynamic information, the incremental prognostic value of early TTE and the significance of normotensive hyperlactatemia remain uncertain. We aimed to develop and validate an initial 2-hour multimodal model integrating clinical, CTA, and TTE data to predict in-hospital mortality and to describe occult shock in normotensive AAD patients.</p><p><strong>Methods: </strong>This retrospective two-centre cohort study included 2,584 adults with first-time AAD who completed CTA and TTE during the initial 2-hour assessment after emergency department triage. Cohorts were development (n=1,678; 2007-2017), internal temporal validation (n=452; 2018-2021), and external geographic/later-era validation (n=454; 2022-March 2024). Candidate variables were restricted to information available during this initial assessment window. Four supervised algorithms were compared, with ablation analyses assessing modality-specific contribution.</p><p><strong>Results: </strong>XGBoost achieved optimism-corrected development area under the curve (AUC) of 0.86 [95% confidence interval (CI): 0.82-0.88], internal validation 0.83 (0.79-0.87), and external validation 0.78 (0.74-0.82). Adding TTE to Clinical + CTA improved discrimination (Delta AUC +0.04, P=0.002) and integrated discrimination improvement (IDI) (+0.021, P=0.01). Normotensive occult shock occurred in 548/2,082 patients (26.3%) and was associated with mortality 15.9% versus 6.7% in metabolically stable normotension.</p><p><strong>Conclusions: </strong>In high-volume aortic centres where CTA and early TTE are routinely available, this initial 2-hour multimodal model showed temporal validation and moderate external discrimination for in-hospital mortality. TTE added prognostic information, particularly for type A disease, and normotensive hyperlactatemia identified a higher-risk subgroup; however, general use, type B performance, local recalibration, and action thresholds require prospective multicentre validation before clinical implementation.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":"16 5","pages":"81"},"PeriodicalIF":2.2,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}